Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Undefined mechanism
>>
Phase 2
Welcome,
Profile
Billing
Logout
1
2
3
4
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
PF-05089771
/ Pfizer
BI 54903
/ Boehringer Ingelheim
PF-04991532
/ Pfizer
HU6
/ Rivus Pharma
NNC0480-0389
/ Novo Nordisk
HRS-7535
/ Jiangsu Hengrui Pharma
MMV390048
/ Medicines for Malaria Venture
SHR-A2009
/ Jiangsu Hengrui Pharma
ganaplacide
(KAF156) / Novartis
BI 1569912
/ Boehringer Ingelheim
LTP001
/ Novartis
Oshadi D
(DNase in Oshadi carrier) / Oshadi Drug Administration
PF-04531083
/ Pfizer
amorphous calcium carbonate
(AMOR 18) / Amorphical Ltd
axomadol
(EN3324) / Endo
janthinobacterium lividum
(DBI-001) / DermBiont
AK3280
/ Ark Biosci
BI 1819479
/ Boehringer Ingelheim
GLY-200
/ Glyscend
NN9541
/ Novo Nordisk
OPS-2071
/ Otsuka
Oshadi R
(RNase in Oshadi carrier) / Oshadi Drug Administration
PF-05190457
/ Pfizer
SHR-1918
/ Jiangsu Hengrui Pharma
brivoligide
(AYX1) / Merck (MSD)
distal jejunal-release dextrose
(APHD-012) / Aphaia Pharma
lipovirtide
(LP-80) / Shanxi Kangbao Bio
APG-157
/ Aveta Biomics
AXA1125
/ Axcella
AZD0780
/ AstraZeneca
BI 1839100
/ Boehringer Ingelheim
CGB-400
/ CAGE Bio
CRD-102
/ Avacta
CRD-102
/ Cardiora
FL058
/ Qilu Pharma
HEC96719
/ HEC Pharm
HRS-1780
/ Jiangsu Hengrui Pharma
HRS-5965
/ Jiangsu Hengrui Pharma
M9466
/ EMD Serono
MK-1942
/ Merck (MSD)
MK-8457
/ Merck (MSD)
MK-8507
/ Merck (MSD)
MK-8527
/ Merck (MSD)
Pro-ocular
(progesterone gel) / Glia, SIFI
SAR447189
/ Teva, Sanofi
SHR-2004
/ Jiangsu Hengrui Pharma
XXB750
/ Novartis
YL201
/ MediLink
domagrozumab
(PF-06252616) / Pfizer
frovocimab
(LY3015014) / Eli Lilly
1
2
3
4
»
